BEACOPP regimen
WikiDoc Resources for BEACOPP regimen |
Articles |
---|
Most recent articles on BEACOPP regimen Most cited articles on BEACOPP regimen |
Media |
Powerpoint slides on BEACOPP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on BEACOPP regimen at Clinical Trials.gov Trial results on BEACOPP regimen Clinical Trials on BEACOPP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on BEACOPP regimen NICE Guidance on BEACOPP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on BEACOPP regimen Discussion groups on BEACOPP regimen Patient Handouts on BEACOPP regimen Directions to Hospitals Treating BEACOPP regimen Risk calculators and risk factors for BEACOPP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for BEACOPP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: BEACOPP; BEACOPP Regimen; BEACOPP regimen; Bleomycin-Etoposide-Adriamycin-Cyclophosphamide-Oncovin-Procarbazine-Prednisone Regimen; Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Procarbazine/Vincristine
Overview
BEACOPP regimen refers to an a chemotherapy regimen consisting of bleomycin, etoposide, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine and prednisone, used for the treatment of advanced-stage Hodgkin lymphoma.[1][2]
Regimen
BBleomycin
EEtoposide
ADoxorubicin (Adriamycin)
CCyclophosphamide
OVincristine (Oncovin)
PProcarbazine
PPrednisone
Indications
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Cheson BD (2014). "Which Hodgkin's patients in the Unites States should be treated with BEACOPP?". Curr Hematol Malig Rep. 9 (3): 222–6. doi:10.1007/s11899-014-0213-6. PMID 24879421.